PTGS2 and glioma: This correlation between the expression levels and the degree of glioma malignancy have been confirmed by Shono et al. who also reported that high COX-2 staining predicts a poor prognosis in patients with glioma in general and in patients with glioblastoma multiform (WHO grade IV) in particular [66].